Javier Marco-Ayala

Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain

E. Barragán, J. Cervera, M. Sanz, 2021, European journal of haematology.

Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question

I. Gómez-Seguí, G. Sanz, P. Solves, 2020, Bone Marrow Transplantation.

IMPACT OF POSTTRANSPLANT CYCLOPHOSPHAMIDE ON TRANSFUSION REQUIREMENTS IN HLA MATCHED SIBLING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.

M. Sanz, J. Sanz, J. de la Rubia, 2023, Transplantation and cellular therapy.

RNA Sequencing Analysis for the Identification of a PCM1/PDGFRB Fusion Gene Responsive to Imatinib

E. Barragán, J. Cervera, M. Sanz, 2019, Acta Haematologica.

Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution

J. Sanz, J. de la Rubia, I. Gómez-Seguí, 2023, Journal of clinical medicine.

Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients

M. Tormo, E. Barragán, M. Sanz, 2021, Leukemia & lymphoma.

CD5+ follicular lymphoma rapidly transformed to high-grade B-cell lymphoma with double-hit: from BCL2 to MYC disruption

F. Ortuño, T. Chen-Liang, R. Teruel-Montoya, 2023, Blood research.